SCHEMBL17357499

SCHEMBL17357499

Cc1c(O)cc(C(=O)c2ccc(O)c(O)c2C)cc1O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 1/20 0.59
▸ ALDH1A1 P00352 3/20 0.41
▸ HPGD P15428 3/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ MAPT P10636 2/20 0.41
▸ ALOX15 P16050 2/20 0.41
▸ RECQL P46063 2/20 0.41
▸ HSD17B10 Q99714 2/20 0.41
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ ALOX12 P18054 1/20 0.40
▸ SELL P14151 1/20 0.39
▸ SELP P16109 1/20 0.39
▸ PTGS2 P35354 2/20 0.37
▸ FASN P49327 1/20 0.37
▸ USP2 O75604 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ KEAP1 Q14145 1/20 0.37
▸ NFE2L2 Q16236 1/20 0.37
▸ ACHE P22303 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19763340 0.89 HDAC1 (0.76) HDAC1ALDH1A1HPGDKDM4EMAPT
SCHEMBL19003405 0.87 HDAC1 (0.53) HDAC1ALDH1A1HPGDKDM4EMAPT
SCHEMBL26441808 0.84 HDAC1 (0.54) HDAC1ALDH1A1HPGDKDM4EMAPT
SCHEMBL26441880 0.80 HDAC1 (0.58) HDAC1ALDH1A1HPGDKDM4EMAPT
SCHEMBL26441706 0.78 HDAC1 (0.70) HDAC1ALDH1A1HPGDKDM4EMAPT
Exifone SCHEMBL273096 0.75 HDAC1 (1.00) HDAC1ALDH1A1HPGDKDM4EMAPT
Exifone SCHEMBL29375026 0.75 HDAC1 (1.00) HDAC1ALDH1A1HPGDKDM4EMAPT
SCHEMBL38623 0.74 SELL (0.64) ALDH1A1HPGDKDM4EMAPTALOX15
SCHEMBL6847401 0.74 HDAC1 (0.84) HDAC1ALDH1A1HPGDKDM4EMAPT
SCHEMBL12672384 0.74 SELL (0.46) HDAC1ALDH1A1HPGDKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150368300-A1 COMPOSITIONS AND METHODS RELATING TO HINDERING DOT1L RECRUITMENT BY MLL-FUSION PROTEINS THE REGENTS OF THE UNIVERSITY OF MICHIGAN 2015-12-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150368300-A1 COMPOSITIONS AND METHODS RELATING TO HINDERING DOT1L RECRUITMENT BY MLL-FUSION PROTEINS MLLT3, MLLT1, DOT1L HDAC1 253/4885ALDH1A1 4036/4885HPGD 4501/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback